UCLA HF Guideline

These agents by work as nitric oxide (NO) donors. The therapeutic role of these agents in HF patients other than African Americans should be further evaluated, but this represents a reasonable option for all HF patients who remain Class III or IV, irrespective of race or ethnicity. Hydralazine 37.5-75 mg tid. Isosorbide dinitrate 20-40 mg tid ................
................